KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Total Debt (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Total Debt for 13 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Debt fell 68.65% to $5.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.0 million, a 68.65% decrease, with the full-year FY2025 number at $5.0 million, down 68.65% from a year prior.
  • Total Debt was $5.0 million for Q4 2025 at Biolife Solutions, down from $7.5 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $26.3 million in Q3 2022 to a low of $2.3 million in Q1 2021.
  • A 5-year average of $15.3 million and a median of $14.4 million in 2024 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: skyrocketed 771.34% in 2021, then tumbled 68.65% in 2025.
  • Biolife Solutions' Total Debt stood at $7.2 million in 2021, then skyrocketed by 259.4% to $25.9 million in 2022, then decreased by 8.04% to $23.8 million in 2023, then tumbled by 33.15% to $15.9 million in 2024, then crashed by 68.65% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Total Debt are $5.0 million (Q4 2025), $7.5 million (Q3 2025), and $10.1 million (Q2 2025).